Lawrence Karsh

5PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 20, 2024
Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS).

Benjamin L Maughan, Yanfang Liu, Suneel Mundle

|Apr 14, 2023
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials.

Emmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka

|Jan 26, 2022
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design.

Neeraj Agarwal, Arun Azad, Neal D Shore

Pageof 1